Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2011-7-4
pubmed:abstractText
Chromosome 3p21 is an important locus harboring critical tumor suppressor genes (TSGs) implicated in the pathogenesis of multiple tumors including esophageal carcinoma (EC). Aberrant promoter methylation is a fundamental mechanism of inactivation of TSGs in cancer. RASSF1A, a candidate tumor suppressor gene, recently cloned from the lung tumor locus at 3p21.3, is frequently inactivated by hypermethylation of its promoter region in a number of malignancies. We undertook this study to investigate the methylation status of RASSF1A and its significance in esophageal squamous cell carcinoma (ESCC).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1873-5487
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 IMSS. Published by Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
182-8
pubmed:meshHeading
pubmed-meshheading:21722812-Adult, pubmed-meshheading:21722812-Aged, pubmed-meshheading:21722812-Carcinoma, Squamous Cell, pubmed-meshheading:21722812-Cell Line, Tumor, pubmed-meshheading:21722812-DNA Methylation, pubmed-meshheading:21722812-Disease-Free Survival, pubmed-meshheading:21722812-Esophageal Neoplasms, pubmed-meshheading:21722812-Female, pubmed-meshheading:21722812-Gene Expression Regulation, Neoplastic, pubmed-meshheading:21722812-Genetic Association Studies, pubmed-meshheading:21722812-Humans, pubmed-meshheading:21722812-Male, pubmed-meshheading:21722812-Middle Aged, pubmed-meshheading:21722812-Neoplasm Staging, pubmed-meshheading:21722812-Prognosis, pubmed-meshheading:21722812-Promoter Regions, Genetic, pubmed-meshheading:21722812-Transcription, Genetic, pubmed-meshheading:21722812-Tumor Suppressor Proteins
pubmed:year
2011
pubmed:articleTitle
Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
pubmed:affiliation
Zhejiang Cancer Research Institute, Zhejiang Province Cancer Hospital, Zhejiang Cancer Center, PR China.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't